Clinical Trials Directory

Trials / Conditions / Muscle Invasive Bladder Cancer (MIBC)

Muscle Invasive Bladder Cancer (MIBC)

8 registered clinical trials studyying Muscle Invasive Bladder Cancer (MIBC) — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingTumor Budding and T1 Substaging in Urothelial Bladder Cancer
NCT07529639
Assiut University—
Not Yet RecruitingProbiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With M
NCT07474064
chenxuPhase 2
Not Yet RecruitingVedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment
NCT07201675
Qilu Hospital of Shandong UniversityPhase 2
RecruitingHome Intravenous Fluid Infusion After Undergoing Radical Cystectomy
NCT07225205
Johns Hopkins UniversityN/A
RecruitingNeoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
NCT07296705
Fujian Medical University Union HospitalPhase 2
Not Yet RecruitingMRI-Guided Bladder Preservation Program For Patients With Muscle Invasive Bladder Cancer
NCT07026864
Clinica Universidad de Navarra, Universidad de NavarraN/A
RecruitingTreatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
NCT07067749
University of Rome Tor VergataPhase 3
RecruitingA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety,
NCT05706129
ITM Oncologics GmbHPhase 1 / Phase 2